N

Nucleus Network | Nucleus Network - Melbourne, Australia

Research site
(Unclaimed)
Location
Level 1, 484 St Kilda Road, Melbourne, Victoria, Australia

Site insights

Top conditions

Top treatments

GC4711
Tricaprilin
NNZ-2566
Tislelizumab
iN1011-N17
Ustekinumab
Tocilizumab
MSB11455
AL01211
ISM5411

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 82 total trials

A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.

A Clinical Trial to Assess Pharmacokinetic Profiles and Safety of IVL3003

Enrolling
Alzheimer Disease
Drug: Aricept Tablet
Drug: IVL3003

The purpose of this study is to evaluate the relative bioavailability of capsule and tablet formulations of TYRA-300-B01, and to evaluate the safety,...

Enrolling
Healthy
Drug: TYRA-300-B01

This is an open-label, two-part study to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of SHR-A1811 and preliminary anti-tum...

Enrolling
Advanced Solid Tumors
Drug: SHR-A1811

This is a multicenter, observer-blind, randomized, controlled phase 3 study to evaluate the immunogenicity, reactogenicity, and safety of an investig...

Active, not recruiting
COVID-19
Other: Placebo
Biological: Influenza vaccine, adjuvanted

The goal of this clinical trial is to learn about ISM5411 in healthy subjects. The primary objective is to evaluate the safety and tolerability of si...

Enrolling
Healthy Subjects
Drug: Placebo
Drug: ISM5411

The purpose of this study is to evaluate the safety and tolerability of intravenously (IV) administered mRNA-0184 at 2 different infusion durations.

Enrolling
Healthy Participants
Drug: mRNA-0184

Trial sponsors

BeiGene logo
R
Arrowhead Pharmaceuticals logo
C
G
I
M
N
A
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems